PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA

被引：0
|
作者：
Kebir, Sied [1 ]
Lazaridis, Lazaros [1 ]
Schmidt, Teresa [1 ]
Oster, Christoph [2 ]
Pierscianek, Daniela [3 ]
Guberina, Nika [2 ]
Kleinschnitz, Christoph [4 ]
Proescholdt, Martin [5 ]
Hau, Peter [5 ]
Grosu, Anca-Ligia [6 ]
Sure, Ulrich [3 ]
Scheffler, Bjoern [2 ]
Stuschke, Martin [7 ]
Glas, Martin [1 ]
机构：
[1] Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany
[2] Univ Hosp Essen, Essen, Germany
[3] Univ Hosp Essen, Dept Neurosurg, Essen, Germany
[4] Univ Hosp Essen, Dept Neurol, Essen, Germany
[5] Univ Hosp Regensburg, Regensburg, Germany
[6] Univ Hosp Freiburg, Freiburg, Germany
[7] Univ Hosp Essen, Dept Radiotherapy, Essen, Germany
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTNI-79
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [31] Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
    Herrlinger, Ulrich
    Rieger, Johannes
    Koch, Dorothee
    Loeser, Simon
    Blaschke, Britta
    Kortmann, Rolf-Dieter
    Steinbach, Joachim P.
    Hundsberger, Thomas
    Wick, Wolfgang
    Meyermann, Richard
    Tan, Ta-Chih
    Sommer, Clemens
    Bamberg, Michael
    Reifenberger, Guido
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4412 - 4417
  • [32] A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
    Ma, Daniel J.
    Galanis, Evanthia
    Anderson, S. Keith
    Schiff, David
    Kaufmann, Timothy J.
    Peller, Patrick J.
    Giannini, Caterina
    Brown, Paul D.
    Uhm, Joon H.
    McGraw, Steven
    Jaeckle, Kurt A.
    Flynn, Patrick J.
    Ligon, Keith L.
    Buckner, Jan C.
    Sarkaria, Jann N.
    NEURO-ONCOLOGY, 2015, 17 (09) : 1261 - 1269
  • [33] PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIOTHERAPY IN ADULTS WITH NEWLY-DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA
    Majd, Nazanin
    Liu, John
    Yeboa, Nana
    Wang, Shuqi
    Weathers, Shiao-Pei
    Yuan, Ying
    Gachimova, Evguenia
    Wathoo, Chetna
    Kamiya-Matsuoka, Carlos
    O'Brien, Barbara
    Aaroe, Ashley
    Patel, Chirag
    Patel, Anuj
    Dagher, Samir
    Wintermark, Max
    Ferguson, Sherise
    Puduvalli, Vinay
    Raleigh, David
    de Groot, John
    NEURO-ONCOLOGY, 2024, 26
  • [34] Phase I trial of the farnesyltransferase inhibitor tipifarnib (R155777) in combination with radiotherapy in patients with newly diagnosed glioblastoma
    Moyal, E. L. Cohen-Jonathan
    Laprie, A.
    Poublanc, M.
    Dalenc, F.
    Toulas, C.
    Alaux, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S200 - S201
  • [35] PHASE I TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Waziri, Allen
    Lillehei, Kevin
    Kleinschmidt-DeMasters, B. K.
    Robischon, Monica
    Stuhr, Kelly
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1066 - 1074
  • [36] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial.
    Saada-Bouzid, Esma
    Frenel, Jean-Sebastien
    Augereau, Paule
    Bourg, Veronique
    Gal, Jocelyn
    Jacquinot, Rique
    Gourmelon, Carole
    Chateau, Yann
    Barriere, Jerome
    Bondiau, Pierre-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Weller, Michael
    Tabatabai, Ghazaleh
    Roelcke, Ulrich
    Hottinger, Andreas
    Joerger, Francisca
    Schmid, Andrea
    Plasswilm, Ludwig
    Schrimpf, Daniel
    Mancao, Christoph
    Capper, David
    Conen, Katrin
    Hundsberger, Thomas
    Caparrotti, Francesca
    von Moos, Roger
    Riklin, Christian
    Felsberg, Joerg
    Roth, Patrick
    Jones, David
    Pfister, Stefan M.
    Rushing, Elisabeth Jane
    Abrey, Lauren
    Reifenberger, Guido
    Held, Leonhard
    von Deimling, Andreas
    Ochsenbein, Adrian
    Wirsching, Hans-Georg
    NEURO-ONCOLOGY, 2017, 19 : 2 - 2
  • [38] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
    Chinot, O. L.
    Rouge, T. de la Motte
    Moore, N.
    Zeaiter, A.
    Das, A.
    Phillips, H.
    Modrusan, Z.
    Cloughesy, T.
    ADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340
  • [39] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom
    Dale R. Shepard
    Manmeet S. Ahluwalia
    Cathy J. Brewer
    Neeraj Agarwal
    Glen H. J. Stevens
    John H. Suh
    Steven A. Toms
    Michael A. Vogelbaum
    Robert J. Weil
    Paul Elson
    Gene H. Barnett
    Journal of Neuro-Oncology, 2010, 98 : 93 - 99
  • [40] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
    O. L. Chinot
    T. de La Motte Rouge
    N. Moore
    A. Zeaiter
    A. Das
    H. Phillips
    Z. Modrusan
    T. Cloughesy
    Advances in Therapy, 2011, 28 : 334 - 340
12345